Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • News

    Risks are reduced when angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers are held before noncardiac surgery

    April 22, 2017

    Is withholding angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) prior to noncardiac surgery associated with a lower risk of a 30-day composite outcome of all-cause death, myocardial injury after noncardiac surgery, and stroke when compared with continuing them on the day of surgery?

  • News

    Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding

    April 19, 2017

    What are the accuracy and clinical utility of risk scoring systems in the assessment of patients with upper gastrointestinal (GI) bleeding?

  • 1
    News

    Patient-to-intensivist ratios can influence patient mortality

    April 19, 2017

    Is there variation in patient-to-intensivist ratios (PIR) across ICUs, and does that ratio affect hospital mortality?

  • 1
    News

    It’s been a good year for heart failure research … mostly

    April 13, 2017

    WASHINGTON – The highs ... and the lows.

  • 1
    Article

    Procalcitonin guidance improves antibiotic stewardship

    April 13, 2017

    Use of the procalcitonin assay has been shown to reduce antibiotic utilization without an increase in adverse outcomes.

  • News

    Uptake of new heart failure drugs slow despite guidelines

    April 5, 2017

    Ivabradine and sacubitril/valsartan reduce mortality and hospitalizations.

  • 1
    News

    New-onset AF boosts bad HFrEF outcomes

    April 4, 2017

    WASHINGTON – Monitor patients with heart failure with reduced ejection fraction for atrial fibrillation.

  • 1
    News

    Data-driven HR, RR parameters might help reduce alarm fatigue

    April 3, 2017

    New research shows data-driven parameters resulted in 55.6% fewer out-of-range vital sign measurements, for CRA, RRT activation.

  • 1
    News

    Sneak Peak: The Hospital Leader Blog

    April 3, 2017

    There is no doubt transparency is important, and patients should be informed when hospitalized as outpatients instead of as inpatients. But the wisdom of the federal NOTICE Act essentially stops there.

  • 1
    News

    Principles learned from a successful improvement program can increase compliance and reduce hospital acquired VTEs (HA-VTEs) across multiple institutions

    March 30, 2017

    Clinical question: Can a single institution's VTE prophylaxis program be scaled to increase prophylaxis and reduce HA-VTEs across multiple institutions?

Previous1 … 290 291 292 293 294 … 401Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences